AGP Executive Report
Last update: 10 hours agoTeen Drug Safety: France warns clinicians after a surge in synthetic cannabinoid poisonings among teens, with many cases tied to “CBD” vaping liquids that may contain potent narcotic compounds. Maternal & Reproductive Health: After the Roe v. Wade overturn, abortion access remains essential, with Planned Parenthood expanding availability via health centers and telehealth. Women’s Health & Equity: A Leicester woman describes years of being dismissed over endometriosis symptoms—highlighting ongoing gaps in diagnosis and care. Access & Affordability: In the US, millions reportedly lost private insurance after federal subsidies expired, worsening cost pressures and coverage gaps. Rural Care Barriers: Rural northern Michigan residents say transport, limited providers, and navigating Medicaid plans delay treatment. Workforce & Capacity: Jersey data show nearly 10,000 emergency visits labeled “primary care,” underscoring strain on community services. Heat & Public Health: Schools across England and Wales close early as an extreme heatwave brings severe health risks. Healthcare Fraud: An Ohio physician faces nearly $1M restitution after a Medicare fraud plea involving unnecessary braces and genetic testing. Innovation & Investment: AbbVie moves to buy Apogee Therapeutics for about $10.9B to strengthen immunology and eczema pipelines.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.